Sommaire
Launch of a consolidation of the Company’s sharesé
Progress update on the medical devices venture listing project
Igny (France) – January 19, 2022 – Archos (Euronext Growth Paris: ALJXR), announces that the extraordinary general meeting of shareholders held today at the first convocation under the chairmanship of Loic Poirier (the “Extraordinary General Meeting”), has approved all the resolutions submitted on an extraordinary basis in accordance with the agenda of the notice of meeting published in BALO n°1 of January 3, 2022.
Information relating to the Extraordinary General Meeting
It is recalled, as indicated in the notices of meeting and convocation relating to the Extraordinary General Meeting, that under the terms of an order of the President of the Commercial Court of Evry dated November 26, 2021, Maître Florence TULIER POLGE, domiciled at Immeuble Le Mazière,rue René Cassin, 91000 Evry, has been appointed as an ad hoc representative to represent the defaulting shareholders on the occasion of the Extraordinary General Meeting to be deliberated.
Le quorum requis pour l’Assemblée Générale Extraordinaire ayant été atteint grâce à la The quorum required for the Extraordinary General Meeting having been reached thanks to the participation of a sufficient number of shareholders, it was immediately put an end to the mission of Maître Florence TULIER POLGE who did not have to intervene in order to allow the quorum to be reached by representing the defaulting shareholders. at the Extraordinary General Meeting. Archos would like to thank all the shareholders who have mobilized.
Participation and quorum
| AGE 19 JANUARY 2022 | Shareholders | Actions | Voice |
| Shareholders present | 5 | 15.529.113 | 16.292.016 |
| Powers mandated to third parties | 1 | 2.612.844 | 2.612.844 |
| Powers to the President | 4 | 43.029.962 | 43.030.734 |
| Postal Votes | 8 | 4.693.788.190 | 4.693.788.193 |
| Total | 18 | 4.754.960.109 | 4.755.723.787 |
The quorum reached for the Extraordinary General Meeting amounts to 30.06% of the 15,816,898,403 shares with voting rights.
Details of the vote by resolution
| No | Wording of the resolution | Quorum at reach | Majority Required | Vote in favour | Vote Against | Abstenti one | Result |
| 1 | Delegation of powers to be granted to the Board of Directors to make a reduction in the share capital motivated by losses, by reducing the nominal value of the shares, subject to the prior completion of the consolidation of the shares of the Company subject to the 1st resolution approved by the extraordinary general meeting of shareholders of the Society of the October 28, 2021 | 3 954 224 601 | 3 169 656 409 | 4 738 284 519 | 17 439 268 | 0 | Adoptee |
| 2 | Delegation of powers to be granted to the Board of Directors to make a reduction in the share capital motivated by losses, by means of a reduction in the nominal value of the shares, subject to the prior realization of the reduction of the share capital motivated by losses, by way of reduction of the nominal value of the Shares of the Company, subject to the 1st resolution presented at this General Meeting | 3 954 224 601 | 3 169 656 409 | 4 738 279 509 | 17 439 268 | 5 010 | Adoptee |
| 3 | Delegation of competence granted to the Board of Directors for the purpose of issuing shares and/or transferable securities giving access to new shares, with the maintenance of the preferential subscription right of Shareholders | 3 954 224 601 | 3 169 656 409 | 4 738 318 743 | 17 405 044 | 0 | Adoptee |
| 4 | Delegation of competence granted to the Board of Directors to issue shares and/or transferable securities giving access to new shares, with the abolition of the preferential subscription right for the benefit of of a class of persons | 3 954 224 601 | 3 169 656 409 | 4 738 284 519 | 17 439 268 | 0 | Adoptee |
The Company recalls that the general meeting of shareholders held on October 28, 2021 approved a resolution allowing the completion of a consolidation of its shares of Archos shares, so that 10,000 old shares with a nominal value of 0.0001 euros are exchanged for 1 new share with a nominal value of 1 euro.
The Board of Directors, meeting on January 18, 2022, decided to launch the consolidation of Archos shares. The process of combining the Company’s shares will therefore take place during the months of February and March 202
Progress update on the medical devices venture listing project
The Company recalls having announced, pursuant to a press release dated June 2, 2021, that it was preparing a proposed IPO of MEDICAL DEVICES VENTURE, a subsidiary of Archos, before the end of 2021.
As such, the Company announces that the listing of MEDICAL DEVICES VENTURE shares in trading on the Euronext Access + Paris market is expected to take place by the end of the first quarter of 2022, subject to Euronext’s approval decision. It is also specified that subscription commitments have been signed by investors for a total amount of €2.3 million, as part of a private placement prior to the listing of MEDICAL DEVICES VENTURE on Euronext Access + Paris (and subject to Euronext’s approval decision), on the basis of a price per share MEDICAL DEVICES VENTURE of €12, which would represent a number of new shares of approximately 191,665 shares and a pre-moneyvaluation of MEDICAL DEVICES VENTURE of€12 million (the current number of shares of MEDICAL DEVICES VENTURE being 1,000,001 shares).
A press release and an information document will be published to announce to the market the effective listing of MEDICAL DEVICES VENTURE on Euronext Access + Paris.
About ARCHOS
ARCHOS, an expert in mobile solutions, has constantly revolutionized this market both in the consumer electronics sector and in B to B with its subsidiary Logic Instrument. The French brand was the first to offer Google Android tablets in 2009. Today, ARCHOS designs and democratizes products with high innovation value and created in 2021 a MedTechdivision, Medical Devices Venture, which will bring together several startups. With headquarters in France, offices in Europe and Asia, ARCHOS is a key pan-European player, listed on the Euronext Growth Paris market, ISIN Code: FR0000182479. www.archos.com
Contact: Loic Poirier, Chairman and Chief Executive Officer, poirier@archos.com
Link to ARCHOS minutes, on their Site:
1 thought on “GM January 19, 2022: Minutes from ARCHOS”